What is the current status of tuberculosis research funding in South Africa?

Many research grants, particularly those from American institutions, have been significantly cut off since early 2025, impacting ongoing TB research.

How does South Africa contribute to global TB research?

South Africa has sophisticated scientific institutions conducting crucial clinical trials for TB treatments, vaccines, and diagnostics.

Why is TB research important in South Africa?

South Africa has one of the highest TB burdens globally, making local research critical for developing effective interventions.

Home / Health / SA TB Research Faces Funding Cuts

SA TB Research Faces Funding Cuts

6 Jan

•

Summary

TB remains the deadliest infectious disease globally, killing over 1.2 million in 2024.
South Africa leads in sophisticated TB research crucial for treatment innovations.
US funding cuts since early 2025 threaten vital tuberculosis research efforts.

Tuberculosis, recognized as humanity's oldest contagious disease, continues to be the world's deadliest infectious ailment, claiming over 1.2 million lives in 2024. While often an afterthought in developed nations, its impact remains severe globally.

South Africa shoulders a significant TB burden but has concurrently developed advanced scientific capabilities dedicated to studying the disease. Clinical trials conducted within the country have been instrumental in driving innovations in TB treatments, vaccines, diagnostics, and prevention strategies, demonstrating a crucial role in the global fight against TB.

However, a substantial portion of the funding for this vital research originates from American institutions. Since early 2025, these funding streams have been significantly reduced due to policy shifts, casting a shadow over the future of TB research and innovation in South Africa and potentially worldwide.